Report #2838886

Overview

Sex

Female

Age

Age unknown

State

—

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Bell's palsy; This serious case was reported by a consumer via call center representative and described the occurrence of bell's palsy in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, several weeks after receiving Shingrix, the patient experienced bell's palsy (Verbatim: Bell's palsy) (serious criteria GSK medically significant). The outcome of the bell's palsy was unknown. It was unknown if the reporter considered the bell's palsy to be related to Shingrix. The company considered the bell's palsy to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 25-APR-2025 The patient was an acquaintance of the reporter. A couple weeks after receiving Shingrix, the patient developed Bell's Palsy. The date of vaccination was not provided and which dose of Shingrix was not provided.; Sender's Comments: Bell's palsy is an unlisted event which is considered unrelated to GSK vaccine Shingrix. US-GSK-US2025050407:Different patient